Delivery Order SPE2DE24DA017-SPE2D625F0UY8
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $3,618.96 on July 18, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by July 23, 2025, and will be performed in Naples, FL. This award was issued without a set-aside designation, reflecting Arthrex's strong competitive...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,024.90 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025, with an ultimate completion date of August 12, 2025. This fixed-price contract with economic price adjustment is a delivery order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471,048,172.66 and running...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a fixed-price delivery order valued at $1,073.17 by the Defense Logistics Agency's Medical Supply Chain on August 21, 2025. The delivery order, which is expected to be completed by August 26, 2025, is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471.0 million and running through September 1,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $5,557.20 by the Defense Logistics Agency's Medical Supply Chain on August 7, 2025. This fixed-price contract with economic price adjustment provisions is designated as a System Implementation Quadrilateral 9MM 1S and will be performed in Naples, Florida, with an ultimate completion date of August 21, 2025. The award is not set aside for any specific business...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,369.50 on August 19, 2025, with an ultimate completion date of August 22, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible for supplying medical equipment and supplies to the Department of Defense and Veterans Affairs...
- Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $8,920.21 on September 9, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment provisions is set to conclude on October 2, 2025, and will be performed at Arthrex's Naples, Florida location. The award represents a task order under Arthrex's larger Indefinite Delivery Contract (IDC) with the...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $3,246.07 on May 20, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by May 28, 2025, and represents a task order issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $56,896.19 on September 8, 2025, with completion targeted for September 22, 2025. This fixed-price delivery order with economic price adjustment was issued under the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The award carries no set-aside designation, reflecting Arthrex's strong competitive position in the federal...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a delivery order valued at $30,577.00 from the Defense Logistics Agency's Medical Supply Chain on August 26, 2025. This fixed-price contract with economic price adjustment provisions is set to conclude by September 10, 2025, and represents a task order under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at $471 million and...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $20,494.91 on August 19, 2025, by the Defense Logistics Agency's Medical Supply Chain division. The delivery order, contract number 4569146560, is for implant systems and secondary fixation bioswalk components (4.75x19.1) and is classified as a fixed-price contract with economic price adjustment provisions. The contract carries an ultimate...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D625F0UY8Delivery Order
Arthrex Inc., a leading orthopedic medical device manufacturer headquartered in Naples, Florida, was awarded a delivery order valued at $1,235.52 on June 4, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, designated as a fixed-price delivery order with economic price adjustment provisions, is scheduled for completion by June 18, 2025, and will be performed in Naples, Florida. This delivery order is issued under Arthrex's larger Indefinite Delivery Contract (SPE2DE24D0020) with the Defense Logistics Agency, valued at approximately $471 million and extending through September 1, 2029, which enables VA medical centers nationwide to procure the company's comprehensive portfolio of orthopedic technologies. The delivery order represents a routine task order issuance under the parent IDC, which supports the federal government's healthcare procurement of advanced orthopedic surgical solutions. Arthrex's contract vehicle covers a broad range of minimally invasive orthopedic products including surgical implants, arthroscopic instruments, joint replacement systems, and specialized surgical kits used across Department of Veterans Affairs and Department of Defense medical facilities. The award was issued without a set-aside designation, reflecting Arthrex's competitive standing in the federal orthopedic medical device marketplace. To date, Arthrex has received over $550,000 in cumulative delivery orders under this IDC, demonstrating sustained demand for its orthopedic technologies across government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 6/4/25 |